Capital Asset Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-16
| Closed | -$2K | – | 412 |
|
|
2022
Q3 | $2K | Sell |
16
-11
| -41% | -$1.38K | ﹤0.01% | 435 |
|
|
2022
Q2 | $3K | Hold |
27
| – | – | ﹤0.01% | 531 |
|
|
2022
Q1 | $4K | Hold |
27
| – | – | ﹤0.01% | 518 |
|
|
2021
Q4 | $4K | Sell |
27
-640
| -96% | -$94.8K | ﹤0.01% | 552 |
|
|
2021
Q3 | $108K | Buy |
667
+7
| +1% | +$1.13K | 0.01% | 453 |
|
|
2021
Q2 | $108K | Buy |
660
+53
| +9% | +$8.67K | 0.01% | 480 |
|
|
2021
Q1 | $91K | Buy |
607
+374
| +161% | +$56.1K | 0.01% | 470 |
|
|
2020
Q4 | $35K | Buy |
233
+15
| +7% | +$2.25K | 0.01% | 696 |
|
|
2020
Q3 | $30K | Buy |
218
+12
| +6% | +$1.65K | 0.01% | 404 |
|
|
2020
Q2 | $27K | Buy |
206
+189
| +1,112% | +$24.8K | 0.01% | 434 |
|
|
2020
Q1 | $2K | Hold |
17
| – | – | ﹤0.01% | 479 |
|
|
2019
Q4 | $2K | Buy |
+17
| New | +$2K | ﹤0.01% | 568 |
|